Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Feb 12, 2016 $12.94 $13.30 $12.48 $13.16 49 000
Feb 11, 2016 $11.99 $12.55 $11.66 $12.07 21 100
Feb 10, 2016 $12.00 $12.60 $11.82 $12.28 36 200
Feb 09, 2016 $12.59 $13.54 $11.40 $12.11 129 800
Feb 08, 2016 $12.67 $13.89 $12.05 $12.61 56 200
Feb 05, 2016 $12.51 $13.63 $12.19 $12.73 50 100
Feb 04, 2016 $12.29 $12.65 $12.29 $12.51 43 200
Feb 03, 2016 $12.92 $13.25 $12.23 $12.34 72 100
Feb 02, 2016 $13.33 $13.46 $12.61 $12.71 51 600
Feb 01, 2016 $13.70 $13.75 $12.20 $12.82 108 500
Jan 29, 2016 $13.06 $13.95 $13.00 $13.90 73 500
Jan 28, 2016 $13.87 $13.87 $12.51 $13.09 103 400
Jan 27, 2016 $13.65 $13.90 $13.54 $13.77 48 500
Jan 26, 2016 $12.91 $13.73 $12.84 $13.56 47 100
Jan 25, 2016 $13.41 $13.41 $12.50 $12.93 69 300
Jan 22, 2016 $12.76 $13.21 $12.60 $12.69 102 300
Jan 21, 2016 $12.83 $12.87 $12.45 $12.52 172 900
Jan 20, 2016 $12.62 $13.00 $12.29 $12.65 135 900
Jan 19, 2016 $12.68 $13.29 $12.68 $12.89 52 200
Jan 15, 2016 $12.25 $12.90 $12.12 $12.60 102 300
Jan 14, 2016 $12.51 $13.05 $12.15 $12.48 91 000
Jan 13, 2016 $13.68 $13.86 $12.08 $12.51 139 900
Jan 12, 2016 $13.94 $14.47 $13.25 $13.39 94 500
Jan 11, 2016 $14.01 $14.47 $13.39 $13.78 123 600
Jan 08, 2016 $14.93 $15.55 $13.43 $13.78 83 100
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT